Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1255 EUR | -12.85% | -65.25% | -93.72% |
May. 29 | Neovacs: mRNA approach validated in preclinical trial | CF |
May. 27 | Neovacs: collaboration contract with INSERM team | CF |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 0.2550 | 0.5100 | 29.99 |
Spread/Res. | -50.78% | -75.39% | -99.58% |
Spread/Supp. | +0.88% | +132.84% | +93.67% |
Support | 0.1244 | 0.0539 | 0.0648 |
- Stock Market
- Equities
- ALNEV Stock
- Charts NEOVACS